Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens

Diagn Microbiol Infect Dis. 2017 Aug;88(4):352-354. doi: 10.1016/j.diagmicrobio.2017.05.009. Epub 2017 May 18.

Abstract

This study assessed the in vitro synergy between ceftazidime, aztreonam, and ceftazidime-avibactam against serine and metallo-β-lactamase (MBL)-producing pathogens via the Etest MIC:MIC ratio and Agar-Etest synergy methods. The combination of aztreonam and ceftazidime-avibactam was synergistic against all Enterobacteriaceae. None of the tested combinations were consistently synergistic against IMP-producing P. aeruginosa.

Keywords: Avibactam; Aztreonam; Carbapenemase; Ceftazidime; Etest; Synergy; beta-Lactamase.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Azabicyclo Compounds / therapeutic use*
  • Aztreonam / therapeutic use*
  • Ceftazidime / therapeutic use*
  • Drug Combinations
  • Drug Synergism
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / metabolism
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / metabolism
  • Serine / metabolism*
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Drug Combinations
  • avibactam, ceftazidime drug combination
  • Serine
  • Ceftazidime
  • beta-Lactamases
  • Aztreonam